ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. SPONSORED CONTENT -- (StatePoint) For Barb, who has ...
Imagine trying to live a normal life when you can’t stop coughing or you’re too breathless to walk. For many people living with bronchiectasis, that’s the reality they face every day. Recurring ...
Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...
Women with a shorter reproductive lifespan are at greater risk of developing bronchiectasis, according to a new study in the July 2026 issue of Chronic Obstructive Pulmonary Diseases: Journal of the ...
Cindy has always been active. As a physical education teacher, and later an elementary school principal, she built her career ...
Non–cystic fibrosis bronchiectasis (NCFB) is a chronic inflammatory condition of the lungs associated with respiratory infections and daily cough and sputum. Non-cystic fibrosis bronchiectasis. Image ...
(StatePoint) For Barb, who has been living with bronchiectasis for nearly 20 years, shortness of breath and an uncontrollable cough were a part of her daily life. She knew something was wrong because ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results